NCT07544394

Brief Summary

This prospective longitudinal study will be conducted in patients diagnosed with Sjögren's disease who are followed at the rheumatology outpatient clinic of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. Demographic and clinical data will be collected from routine clinical assessments and medical records, including laboratory results obtained during standard care. Participants will undergo evaluation of pressure pain threshold using a digital algometer and complete validated questionnaires assessing fatigue, disease activity, patient-reported symptoms, anxiety and depression, pain catastrophizing, sleep quality, and physical activity level. All assessments will be performed at baseline and repeated at follow-up visits approximately 3 months later.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
23mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Apr 2026Apr 2028

First Submitted

Initial submission to the registry

April 15, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

April 20, 2026

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2028

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

1.7 years

First QC Date

April 15, 2026

Last Update Submit

April 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Multidimensional Fatigue Inventory-20 (MFI-20)

    The MFI-20 is a 20-item self-reported questionnaire assessing fatigue across five dimensions: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. Each item is scored on a 5-point Likert scale. Total scores range from 20 to 100, with higher scores indicating greater fatigue.

    Baseline and 3-month

Secondary Outcomes (7)

  • EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)

    Baseline and 3-month

  • EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI)

    Baseline and 3-month

  • Pressure Pain Threshold (PPT)

    Baseline and 3-month

  • Hospital Anxiety and Depression Scale (HADS)

    Baseline and 3-month

  • Pain Catastrophizing Scale (PCS)

    Baseline and 3-month

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Participants will be recruited from the rheumatology outpatient clinics of Kahramanmaras Sutcu Imam University Medical Faculty Hospital. The study population will consist of adult patients diagnosed with Sjögren's disease who are followed in routine clinical care.

You may qualify if:

  • Diagnosis of Sjögren's syndrome
  • Age ≥ 18 years
  • Willingness to participate and provide written informed consent

You may not qualify if:

  • Presence of severe somatic or psychiatric disorders
  • Presence of malignancy
  • Pregnancy
  • Refusal to participate or inability to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kahramanmaras Sutcu Imam University

Kahramanmaraş, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Sjogren's SyndromeFatigue

Condition Hierarchy (Ancestors)

Arthritis, RheumatoidArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesXerostomiaSalivary Gland DiseasesMouth DiseasesStomatognathic DiseasesDry Eye SyndromesLacrimal Apparatus DiseasesEye DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Nazli Elif Nacar, phd

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist, PhD

Study Record Dates

First Submitted

April 15, 2026

First Posted

April 22, 2026

Study Start

April 20, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

April 20, 2028

Last Updated

April 27, 2026

Record last verified: 2026-04

Locations